Outcomes of the Bethesda system for reporting thyroid cytopathology: Real-life experience

被引:5
作者
Avior, Galit [1 ,2 ]
Dagan, Or [1 ]
Shochat, Isaac [1 ]
Frenkel, Yulia [1 ]
Tessler, Idit [3 ]
Meir, Alona [4 ]
Jaffe, Anat [5 ]
Cohen, Oded [3 ]
机构
[1] Hillel Yaffe Med Ctr, Otorhinolaryngol & Head & Neck Surg, Hadera, Israel
[2] Technion, Fac Med, Haifa, Israel
[3] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel
[4] Hillel Yaffe Med Ctr, Dept Pathol, Hadera, Israel
[5] Hillel Yaffe Med Ctr, Endocrinol & Diabet Unit, Hadera, Israel
关键词
FINE-NEEDLE-ASPIRATION; NODULE SIZE; MALIGNANCY; MANAGEMENT; CYTOLOGY; BIOPSY; IMPACT; RISK; CLASSIFIER; ULTRASOUND;
D O I
10.1111/cen.14341
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The 2017 revised Bethesda System for Reporting Thyroid Cytopathology (BSRTC) included new malignancy rates for each category as well as new management recommendations. Here, we evaluate the malignancy rate and test performance for BSRTC categories in a middle-sized institution outside the United States (US). Design Retrospective single centre case series with chart review. Patients All patients who underwent thyroid surgery with a preoperative BSRTC between the years 2010 and 2018 at our institution. Measurements In order to assess the malignancy rate for each BSRTC, all medical records were reviewed to collect demographics, nodule's size, BSRTC and final pathology. Results Three hundred and sixty-four patients were included, with an overall malignancy rate of 34.3%. The malignancy rate for BSRTC categories I-VI was as follows: 13.3%, 5.1%, 25.0%, 24.4%, 91.3% and 95.2%, respectively. The most sensitive test was when BSRTC III-VI were evaluated (91%). Overall best performance (sensitivity, specificity, PPV, NPV and accuracy) was obtained when BSRTC V-VI were grouped together with a substantial decrease when adding BSRTC III-IV (90%, 97%, 94%, 95%, 95% vs, respectively, 91%, 73%, 62%, 95%, 79%, respectively). Conclusions Despite differences from the reported 2017 BSRTC malignancy rates, we demonstrated that the revised 2017 BSRTC management recommendations for thyroid nodules are also valid in smaller non-US centre, supporting its use globally.
引用
收藏
页码:521 / 527
页数:7
相关论文
共 50 条
[31]   Incidence and malignancy rates classified by The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) - An 8-year tertiary center experience in Thailand [J].
Thewjitcharoen, Yotsapon ;
Butadej, Siriwan ;
Nakasatien, Soontaree ;
Chotwanvirat, Phawinpon ;
Porramatikul, Sriurai ;
Krittiyawong, Sirinate ;
Lekpittaya, Nampetch ;
Himathongkam, Thep .
JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2019, 16
[32]   The interobserver reproducibility of thyroid cytopathology using Bethesda Reporting System: Analysis of 200 cases [J].
Ahmed, Safina ;
Ahmad, Mumtaz ;
Khan, Masood Ahmad ;
Kazi, Faiza ;
Noreen, Fozia ;
Nawaz, Samia ;
Sohail, Iram .
JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2013, 63 (10) :1252-1255
[33]   A study of malignancy rates in different diagnostic categories of the Bethesda system for reporting thyroid cytopathology: An institutional experience [J].
Arul, P. ;
Akshatha, C. ;
Masilamani, Suresh .
BIOMEDICAL JOURNAL, 2015, 38 (06) :517-522
[34]   Cytological diagnosis of pediatric thyroid nodule in perspective of the Bethesda System for Reporting Thyroid Cytopathology [J].
Pantola, Chayanika ;
Kala, Sanjay ;
Khan, Lubna ;
Pantola, Saurabh ;
Singh, Mahendra ;
Verma, Sumanlata .
JOURNAL OF CYTOLOGY, 2016, 33 (04) :220-223
[35]   Reproducibility of the Bethesda System for Reporting Thyroid Cytopathology: A Methodological Issue [J].
Naderi, Mehdi ;
Sabour, Siamak .
JOURNAL OF CYTOLOGY, 2019, 36 (03) :185-+
[36]   Usefulness of The Bethesda System of Reporting Thyroid Cytopathology in Surgical Planning [J].
Swetal Mahajan ;
B. V. Manjula ;
R. Vaishnavi ;
Neena John ;
Bhuvaneshwari Babu .
Indian Journal of Otolaryngology and Head & Neck Surgery, 2022, 74 :2623-2628
[37]   Efficiency of the Bethesda System for Thyroid Cytopathology [J].
Mora-Guzman, Ismael ;
Munoz de Nova, Jose Luis ;
Marin-Campos, Cristina ;
Antonio Jimenez-Heffernan, Jose ;
Cuesta Perez, Juan Julian ;
Lahera Vargas, Marcos ;
Torres Minguez, Emma ;
Martin-Perez, Elena .
CIRUGIA ESPANOLA, 2018, 96 (06) :363-368
[38]   Application of the Bethesda system for reporting thyroid cytopathology for classification of thyroid nodules: A clinical and cytopathological characteristics in Bhutanese population [J].
Choden, Sonam ;
Wangmo, Chimi ;
Maharjan, Sushna .
DIAGNOSTIC CYTOPATHOLOGY, 2021, 49 (11) :1179-1187
[39]   Atypia of Undetermined Significance and Nondiagnostic Rates in The Bethesda System for Reporting Thyroid Cytopathology Are Inversely Related [J].
VanderLaan, Paul A. ;
Renshaw, Andrew A. ;
Krane, Jeffrey F. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (03) :462-465
[40]   Malignancy Risk for Fine-Needle Aspiration of Thyroid Lesions According to The Bethesda System for Reporting Thyroid Cytopathology [J].
Jo, Vickie Y. ;
Stelow, Edward B. ;
Dustin, Simone M. ;
Hanley, Krisztina Z. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (03) :450-456